IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates BAP1. 1 / 1

| 1

reach

"Next, 293T cells were cotransfected with wild-type BAP1 or C91S mutant and UBE2O, and then treated with the proteasome inhibitor MG132."

24703950

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates BAP1. 1 / 1

INDRA sources:

Databases

Reading